Screener
UroGen Pharma URGN Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from UroGen Pharma’s reported figures.
Based on trailing twelve months.
The source filing: UroGen Pharma’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 8:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025794
FAQ
- What is UroGen Pharma's net margin?
- UroGen Pharma (URGN) reported net margin of -51.7% in Q2 2026.
- How has UroGen Pharma's net margin changed year-over-year?
- UroGen Pharma's net margin increased by 68.5% year-over-year, from -164.4% to -51.7%.
- What is the long-term trend for UroGen Pharma's net margin?
- Over 5 years (2020 to 2025), UroGen Pharma's net margin has grown at a -33.7% compound annual growth rate (CAGR), from -1,088.9% to -139.8%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about UroGen Pharma's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude